Clinical TrialsSearch results
Number of results: 315
Other
- Rituximab + standard CHOP (R S-CHOP) vs Rituximab + bi-weekly CHOP (R Bi-CHOP) RCT(phase II/III) low-grade B-cell lymphoma at advanced stage (LowBNHL-RS/BiCHOP-P2/3) (JCOG0203)
- Untreated CD20-positive low-grade B-cell lymphoma at advanced stage
- Japan Clinical Oncology Group(JCOG)
- 2005-07-30
Other
- Risk Factors and Therapies for Gastric Variceal Bleeding in Japan:retrospective study
- Gastric fundal varices without history of bleeding
- National Hospital Organization Head quarter
- 2007-09-01
Other
- Risk Factors and Therapies for Gastric Variceal Bleeding in Japan:prospective study
- Patients with ruptured gastric fundal varices
- National Hospital Organization Head quarter
- 2007-09-01
Other
- Research study of QOL with leukotriene receptor antagonist ,pranlukast in asthmatic patients by use of Asthma Health Questionnaire-Japan QOL (AHQ-JAPAN QOL)
- Asthma
- Asthma QOL Research Study Group
- 2007-06-01
Other
- Research for the international hermonization of molecular responce criteria in chronic myelogenous leukemia
- chronic myeloid leukemia
- Kanto CML Study Group
- 2009-03-03
Other
- Registration study on acutely decompensated heart failure
- heart failure
- Keio Interhospital Cardiology Study Group
- 2008-06-02
Other
- Registration Program for Myelodysplastic Syndromes and Aplastic Anemia
- Myelodysplastic Syndromes Aplastic Anemia
- Keio University School of Medicine
- 2007-04-28
Other
- Randomized, double-blind, placebo-controlled study of AMG0001(HGF plasmid) for patients with arteriosclerosis obliterans
- Arteriosclerosis obliterans
- Anges MG, Inc.
- 2007-06-04
Other
- Randomized, double-blind, placebo-controlled multi center clinical trial for the prevention of chronic lung disease in extremely low birth weight infants with inhaled fluticasone propionate
- chronic lung disease in extremely low birth weight infants
- Neonatal Research Network Japan
- 2006-04-12
Other
- Randomized, controlled trial of early intervention with pranlukast for prevention of bronchial asthma in infants with wheezy bronchitis and atopy
- Infants between 1 and 3 years old, who have severe atopy defined by class 2 and more of Ig E to food and/or environment allergens and history of wheezy bronchitis twice.
- Japanese Society of Pediatric Allergy and Clinical Immunology
- 2007-04-01